H A Korkmaz1, U Karaarslan2, C Eraslan3, D Atila4, F Hazan5, V Barışık6, E S Ata7, O Etlik8, M Yıldız1, B Ozkan1. 1. "Dr.Behcet Uz" Children Disease and Surgery Training and Research Hospital, Pediatric Endocrinology Clinic, İstanbul, Turkey. 2. Dokuz Eylul University - Pediatrics Clinic, İstanbul, Turkey. 3. Ege University Medical School - Dept. of Radiology, İstanbul, Turkey. 4. Izmir Public Health Directorate - Dept. of Family Medicine, İstanbul, Turkey. 5. "Dr.Behcet Uz" Children Disease and Surgery Training and Research Hospital - Dept. of Medical Genetics, İstanbul, Turkey. 6. Metropol Medicine Center - Dept. of Internal Medicine, Izmir, İstanbul, Turkey. 7. Uşak State Hospital - Dept. of Radiology, Uşak, İstanbul, Turkey. 8. BURC Molecular Diagnostic Laboratories - Dept. of Medical Genetics, İstanbul, Turkey.
Abstract
OBJECTIVE: Ectopic posterior pituitary gland (EPP) is usually characterized by an abnormal pituitary stalk and hypoplasia of the anterior hypophysis. The genetic mechanisms involved in the development of EPP remain uncertain. The aim of this study is to determine whether mutations in the three genes, PROP-1, LHX2, and POU1F1, are associated with the risk for and the characteristics of EPP. METHODS: In the Endocrinology Outpatient Clinic of "Dr. Behcet Uz" Children's Hospital, 27 patients with EPP were submitted to sequencing analyses of the PROP-1, LHX2, and POU1F1 genes. RESULTS: Growth hormone, thyrotropin, corticotropin, gonadotropin, and vasopressin deficiency were observed in 22 (81.5%), 23 (85.2%), 17 (63%), 14 (51.9%), and two (7.4%) patients. Thirteen patients (48.1%) presented with hyperprolactinemia. Fourteen patients (51%) had a history of birth dystocia, and 12 cases (42.1%) had a history of breech presentation. Central nervous system abnormalities included five cases with corpus callosum agenesis, one case with schizencephaly, and one case with Chiari type 1 malformation. We identified a homozygous p.S109* mutation in exon 2 in one male patient with EPP and two different PROP1 gene polymorphisms (A142T or c.109+3 G>A polymorphism) in thirteen patients. CONCLUSIONS: Our results suggest that PROP1 gene abnormalities might explain the genetic mechanisms involved in the development of EPP.
OBJECTIVE: Ectopic posterior pituitary gland (EPP) is usually characterized by an abnormal pituitary stalk and hypoplasia of the anterior hypophysis. The genetic mechanisms involved in the development of EPP remain uncertain. The aim of this study is to determine whether mutations in the three genes, PROP-1, LHX2, and POU1F1, are associated with the risk for and the characteristics of EPP. METHODS: In the Endocrinology Outpatient Clinic of "Dr. Behcet Uz" Children's Hospital, 27 patients with EPP were submitted to sequencing analyses of the PROP-1, LHX2, and POU1F1 genes. RESULTS: Growth hormone, thyrotropin, corticotropin, gonadotropin, and vasopressin deficiency were observed in 22 (81.5%), 23 (85.2%), 17 (63%), 14 (51.9%), and two (7.4%) patients. Thirteen patients (48.1%) presented with hyperprolactinemia. Fourteen patients (51%) had a history of birth dystocia, and 12 cases (42.1%) had a history of breech presentation. Central nervous system abnormalities included five cases with corpus callosum agenesis, one case with schizencephaly, and one case with Chiari type 1 malformation. We identified a homozygous p.S109* mutation in exon 2 in one male patient with EPP and two different PROP1 gene polymorphisms (A142T or c.109+3 G>A polymorphism) in thirteen patients. CONCLUSIONS: Our results suggest that PROP1 gene abnormalities might explain the genetic mechanisms involved in the development of EPP.
Authors: P Q Thomas; M T Dattani; J M Brickman; D McNay; G Warne; M Zacharin; F Cameron; J Hurst; K Woods; D Dunger; R Stanhope; S Forrest; I C Robinson; R S Beddington Journal: Hum Mol Genet Date: 2001-01-01 Impact factor: 6.150
Authors: S Vallette-Kasic; A Barlier; C Teinturier; A Diaz; M Manavela; F Berthezène; P Bouchard; J L Chaussain; R Brauner; I Pellegrini-Bouiller; P Jaquet; A Enjalbert; T Brue Journal: J Clin Endocrinol Metab Date: 2001-09 Impact factor: 5.958
Authors: J Deladoëy; C Flück; A Büyükgebiz; B V Kuhlmann; A Eblé; P C Hindmarsh; W Wu; P E Mullis Journal: J Clin Endocrinol Metab Date: 1999-05 Impact factor: 5.958
Authors: Kathryn S Woods; Maria Cundall; James Turton; Karine Rizotti; Ameeta Mehta; Rodger Palmer; Jacqueline Wong; W K Chong; Mahmoud Al-Zyoud; Maryam El-Ali; Timo Otonkoski; Juan-Pedro Martinez-Barbera; Paul Q Thomas; Iain C Robinson; Robin Lovell-Badge; Karen J Woodward; Mehul T Dattani Journal: Am J Hum Genet Date: 2005-03-30 Impact factor: 11.025